Works by Cleary, James M.

Results: 33
    1
    2

    A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00214-y
    By:
    • Mansfield, Aaron S.;
    • Hong, David S.;
    • Hann, Christine L.;
    • Farago, Anna F.;
    • Beltran, Himisha;
    • Waqar, Saiama N.;
    • Hendifar, Andrew E.;
    • Anthony, Lowell B.;
    • Taylor, Matthew H.;
    • Bryce, Alan H.;
    • Tagawa, Scott T.;
    • Lewis, Karl;
    • Niu, Jiaxin;
    • Chung, Christine H.;
    • Cleary, James M.;
    • Rossi, Michael;
    • Ludwig, Carrianne;
    • Valenzuela, Ricardo;
    • Luo, Yan;
    • Aggarwal, Rahul
    Publication type:
    Article
    3

    Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.

    Published in:
    JNCI Cancer Spectrum, 2022, v. 6, n. 2, p. 1, doi. 10.1093/jncics/pkac014
    By:
    • McCleary, Nadine J;
    • Harmsen, William S;
    • Haakenstad, Ellana;
    • Cleary, James M;
    • Meyerhardt, Jeffrey A;
    • Zalcberg, John;
    • Adams, Richard;
    • Grothey, Axel;
    • Sobrero, Alberto F;
    • Cutsem, Eric Van;
    • Goldberg, Richard M;
    • Peeters, Marc;
    • Tabernero, Josep;
    • Seymour, Matt;
    • Saltz, Leonard B;
    • Giantonio, Bruce J;
    • Arnold, Dirk;
    • Rothenberg, Mace L;
    • Koopman, Miriam;
    • Schmoll, Hans-Joachim
    Publication type:
    Article
    4
    5

    Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma.

    Published in:
    Cancers, 2022, v. 14, n. 24, p. 6223, doi. 10.3390/cancers14246223
    By:
    • Huffman, Brandon M.;
    • Ellis, Haley;
    • Jordan, Alexander C.;
    • Freed-Pastor, William A.;
    • Perez, Kimberly;
    • Rubinson, Douglas A.;
    • Sethi, Nilay;
    • Singh, Harshabad;
    • Surana, Rishi;
    • Wolpin, Brian M.;
    • Aguirre, Andrew J.;
    • Cleary, James M.
    Publication type:
    Article
    6
    7

    Effect of High-Dose vs Standard-Dose Vitamin D 3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3451, doi. 10.3390/cancers12113451
    By:
    • Brown, Justin C.;
    • Rosenthal, Michael H.;
    • Ma, Chao;
    • Zhang, Sui;
    • Nimeiri, Halla S.;
    • McCleary, Nadine J.;
    • Abrams, Thomas A.;
    • Yurgelun, Matthew B.;
    • Cleary, James M.;
    • Rubinson, Douglas A.;
    • Schrag, Deborah;
    • Bullock, Andrea J.;
    • Allen, Jill;
    • Zuckerman, Dan;
    • Chan, Emily;
    • Chan, Jennifer A.;
    • Wolpin, Brian;
    • Constantine, Michael;
    • Weckstein, Douglas J.;
    • Faggen, Meredith A.
    Publication type:
    Article
    8

    NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 3, p. 476, doi. 10.1038/s41416-023-02534-1
    By:
    • Cecchini, Michael;
    • Cleary, James M.;
    • Shyr, Yu;
    • Chao, Joseph;
    • Uboha, Nataliya;
    • Cho, May;
    • Shields, Anthony;
    • Pant, Shubham;
    • Goff, Laura;
    • Spencer, Kristen;
    • Kim, Edward;
    • Stein, Stacey;
    • Kortmansky, Jeremy S.;
    • Canosa, Sandra;
    • Sklar, Jeffrey;
    • Swisher, Elizabeth M.;
    • Radke, Marc;
    • Ivy, Percy;
    • Boerner, Scott;
    • Durecki, Diane E.
    Publication type:
    Article
    9

    Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.

    Published in:
    2017
    By:
    • Mita, Monica M;
    • Mita, Alain C;
    • Moseley, Jennifer L;
    • Poon, Jennifer;
    • Small, Karen A;
    • Jou, Ying-Ming;
    • Kirschmeier, Paul;
    • Zhang, Da;
    • Zhu, Yali;
    • Statkevich, Paul;
    • Sankhala, Kamelesh K;
    • Sarantopoulos, John;
    • Cleary, James M;
    • Chirieac, Lucian R;
    • Rodig, Scott J;
    • Bannerji, Rajat;
    • Shapiro, Geoffrey I
    Publication type:
    journal article
    10
    11
    12

    Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51271-3
    By:
    • Singh, Harshabad;
    • Lowder, Kristen E.;
    • Kapner, Kevin;
    • Kelly, Ronan J.;
    • Zheng, Hui;
    • McCleary, Nadine Jackson;
    • Abrams, Thomas A.;
    • Chan, Jennifer A.;
    • Regan, Eileen M.;
    • Klempner, Samuel J.;
    • Hannigan, Alison M.;
    • Remland, Joshua;
    • Brais, Lauren K.;
    • Andrews, Elizabeth;
    • Yurgelun, Matthew;
    • Cleary, James M.;
    • Rubinson, Douglas A.;
    • Ritterhouse, Lauren L.;
    • Maron, Garrett;
    • Aguirre, Andrew J.
    Publication type:
    Article
    13

    Dose‐escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF‐mutant solid tumors.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 12, p. 1904, doi. 10.1002/cncr.34730
    By:
    • Mooradian, Meghan J.;
    • Cleary, James M.;
    • Giobbie‐Hurder, Anita;
    • Darville, Lancia N. F.;
    • Parikh, Aparna;
    • Buchbinder, Elizabeth I.;
    • Cohen, Justine V.;
    • Lawrence, Donald P.;
    • Shapiro, Geoffrey I.;
    • Keer, Harold;
    • Chen, Helen X.;
    • Ivy, Susan Percy;
    • Smalley, Keiran S. M.;
    • Koomen, John M.;
    • Sullivan, Ryan J.
    Publication type:
    Article
    14

    FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.

    Published in:
    2019
    By:
    • Cleary, James M.;
    • Horick, Nora K.;
    • McCleary, Nadine Jackson;
    • Abrams, Thomas A.;
    • Yurgelun, Matthew B.;
    • Azzoli, Christopher G.;
    • Rubinson, Douglas A.;
    • Brooks, Gabriel A.;
    • Chan, Jennifer A.;
    • Blaszkowsky, Lawrence S.;
    • Clark, Jeffrey W.;
    • Goyal, Lipika;
    • Meyerhardt, Jeffrey A.;
    • Ng, Kimmie;
    • Schrag, Deborah;
    • Savarese, Diane M. F.;
    • Graham, Christopher;
    • Fitzpatrick, Bridget;
    • Gibb, Kathryn A.;
    • Boucher, Yves
    Publication type:
    journal article
    15
    16
    17
    18
    19
    20

    High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors.

    Published in:
    Science Signaling, 2020, v. 13, n. 636, p. 1, doi. 10.1126/scisignal.aay1451
    By:
    • Bhola, Patrick D.;
    • Ahmed, Eman;
    • Guerriero, Jennifer L.;
    • Sicinska, Ewa;
    • Su, Emily;
    • Lavrova, Elizaveta;
    • Ni, Jing;
    • Chipashvili, Otari;
    • Hagan, Timothy;
    • Pioso, Marissa S.;
    • McQueeney, Kelley;
    • Ng, Kimmie;
    • Aguirre, Andrew J.;
    • Cleary, James M.;
    • Cocozziello, David;
    • Sotayo, Alaba;
    • Ryan, Jeremy;
    • Zhao, Jean J.;
    • Letai, Anthony
    Publication type:
    Article
    21

    Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 1, p. e2249720, doi. 10.1001/jamanetworkopen.2022.49720
    By:
    • Huffman, Brandon M.;
    • Basu Mallick, Atrayee;
    • Horick, Nora K.;
    • Wang-Gillam, Andrea;
    • Hosein, Peter Joel;
    • Morse, Michael A.;
    • Beg, Muhammad Shaalan;
    • Murphy, Janet E.;
    • Mavroukakis, Sharon;
    • Zaki, Anjum;
    • Schlechter, Benjamin L.;
    • Sanoff, Hanna;
    • Manz, Christopher;
    • Wolpin, Brian M.;
    • Arlen, Philip;
    • Lacy, Jill;
    • Cleary, James M.
    Publication type:
    Article
    22

    Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.

    Published in:
    2019
    By:
    • Ng, Kimmie;
    • Nimeiri, Halla S.;
    • McCleary, Nadine J.;
    • Abrams, Thomas A.;
    • Yurgelun, Matthew B.;
    • Cleary, James M.;
    • Rubinson, Douglas A.;
    • Schrag, Deborah;
    • Miksad, Rebecca;
    • Bullock, Andrea J.;
    • Allen, Jill;
    • Zuckerman, Dan;
    • Chan, Emily;
    • Chan, Jennifer A.;
    • Wolpin, Brian M.;
    • Constantine, Michael;
    • Weckstein, Douglas J.;
    • Faggen, Meredith A.;
    • Thomas, Christian A.;
    • Kournioti, Chryssanthi
    Publication type:
    journal article
    23
    24
    25

    Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma Patients.

    Published in:
    Cancer (0008543X), 2010, v. 116, n. 23, p. 5400, doi. 10.1002/cncr.25583
    By:
    • Zama, Ivan N.;
    • Hutson, Thomas E.;
    • Elson, Paul;
    • Cleary, James M.;
    • Choueiri, Toni K.;
    • Heng, Daniel Y. C.;
    • Ramaiya, Nikhil;
    • Michaelson, M. Dror;
    • Garcia, Jorge A.;
    • Knox, Jennifer J.;
    • Escudier, Bernard;
    • Rini, Brian I.
    Publication type:
    Article
    26

    Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.

    Published in:
    Oncologist, 2023, v. 28, n. 5, p. 425, doi. 10.1093/oncolo/oyad002
    By:
    • Perez, Kimberly;
    • Chiarella, Anna M;
    • Cleary, James M;
    • Horick, Nora;
    • Weekes, Colin;
    • Abrams, Thomas;
    • Blaszkowsky, Lawrence;
    • Enzinger, Peter;
    • Giannakis, Marios;
    • Goyal, Lipika;
    • Meyerhardt, Jeffrey A;
    • Rubinson, Douglas;
    • Yurgelun, Matthew B;
    • Goessling, Wolfram;
    • Giantonio, Bruce J;
    • Brais, Lauren;
    • Germon, Victoria;
    • Stonely, Danielle;
    • Raghavan, Srivatsan;
    • Bakir, Basil
    Publication type:
    Article
    27

    Preemptive Versus Reactive Topical Clobetasol for Regorafenib‐Induced Hand‐Foot Reactions: A Preplanned Analysis of the ReDOS Trial.

    Published in:
    Oncologist, 2021, v. 26, n. 7, p. 610, doi. 10.1002/onco.13730
    By:
    • Jatoi, Aminah;
    • Ou, Fang‐Shu;
    • Ahn, Daniel H.;
    • Zemla, Tyler J.;
    • Le‐Rademacher, Jennifer G.;
    • Boland, Patrick;
    • Ciombor, Kristen K.;
    • Jacobs, Nisha L.;
    • Pasche, Boris;
    • Cleary, James M.;
    • McCune, Jeannine S.;
    • Pedersen, Katrina S.;
    • Barzi, Afsaneh;
    • Chiorean, E. Gabriela;
    • Heying, Erica N.;
    • Lenz, Heinz‐Josef;
    • Sloan, Jeff A.;
    • Grothey, Axel;
    • Lacouture, Mario E.;
    • Bekaii‐Saab, Tanios
    Publication type:
    Article
    28

    Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma.

    Published in:
    Oncologist, 2014, v. 19, n. 6, p. 637, doi. 10.1634/theoncologist.2014-0086
    By:
    • Wolpin, Brian M.;
    • Rubinson, Douglas A.;
    • Wang, Xiaoxu;
    • Chan, Jennifer A.;
    • Cleary, James M.;
    • Enzinger, Peter C.;
    • Fuchs, Charles S.;
    • McCleary, Nadine J.;
    • Meyerhardt, Jeffrey A.;
    • Ng, Kimmie;
    • Schrag, Deborah;
    • Sikora, Allison L.;
    • Spicer, Beverly A.;
    • Killion, Leah;
    • Mamon, Harvey;
    • Kimmelman, Alec C.
    Publication type:
    Article
    29

    Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36399-y
    By:
    • Harding, James J.;
    • Piha-Paul, Sarina A.;
    • Shah, Ronak H.;
    • Murphy, Jessica J.;
    • Cleary, James M.;
    • Shapiro, Geoffrey I.;
    • Quinn, David I.;
    • Braña, Irene;
    • Moreno, Victor;
    • Borad, Mitesh;
    • Loi, Sherene;
    • Spanggaard, Iben;
    • Park, Haeseong;
    • Ford, James M.;
    • Arnedos, Mónica;
    • Stemmer, Salomon M.;
    • de la Fouchardiere, Christelle;
    • Fountzilas, Christos;
    • Zhang, Jie;
    • DiPrimeo, Daniel
    Publication type:
    Article
    30

    Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36399-y
    By:
    • Harding, James J.;
    • Piha-Paul, Sarina A.;
    • Shah, Ronak H.;
    • Murphy, Jessica J.;
    • Cleary, James M.;
    • Shapiro, Geoffrey I.;
    • Quinn, David I.;
    • Braña, Irene;
    • Moreno, Victor;
    • Borad, Mitesh;
    • Loi, Sherene;
    • Spanggaard, Iben;
    • Park, Haeseong;
    • Ford, James M.;
    • Arnedos, Mónica;
    • Stemmer, Salomon M.;
    • de la Fouchardiere, Christelle;
    • Fountzilas, Christos;
    • Zhang, Jie;
    • DiPrimeo, Daniel
    Publication type:
    Article
    31
    32

    A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 5, p. 1483, doi. 10.1007/s10637-020-00908-3
    By:
    • Cleary, James M.;
    • Calvo, Emiliano;
    • Moreno, Victor;
    • Juric, Dejan;
    • Shapiro, Geoffrey I.;
    • Vanderwal, Carol Ann;
    • Hu, Beibei;
    • Gifford, Maryella;
    • Barch, David;
    • Roberts-Rapp, Lisa;
    • Ansell, Peter J.;
    • Xiong, Hao;
    • Ocampo, Christopher;
    • Tolcher, Anthony W.
    Publication type:
    Article
    33

    Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 2, p. 419, doi. 10.1007/s10637-019-00776-6
    By:
    • Shapiro, Geoffrey I.;
    • LoRusso, Patricia;
    • Kwak, Eunice;
    • Pandya, Susan;
    • Rudin, Charles M.;
    • Kurkjian, Carla;
    • Cleary, James M.;
    • Pilat, Mary Jo;
    • Jones, Suzanne;
    • de Crespigny, Alex;
    • Fredrickson, Jill;
    • Musib, Luna;
    • Yan, Yibing;
    • Wongchenko, Matthew;
    • Hsieh, Hsin-Ju;
    • Gates, Mary R.;
    • Chan, Iris T.;
    • Bendell, Johanna
    Publication type:
    Article